Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03164486 · ClinicalTrials.gov registry record · Early Phase 1
First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide
A Early Phase 1 study of Breast Carcinoma and Colorectal Carcinoma, sponsored by Julie L. Sutcliffe, Ph.D.
- Active
- Registry status
- Early Phase 1
- Development phase
- 27
- Enrollment target
- 1
- Study location
NCT03164486 is a Early Phase 1 study of Breast Carcinoma and Colorectal Carcinoma that is active but no longer recruiting, run by Julie L. Sutcliffe, Ph.D. The registered enrollment target is 27 participants, below the 770-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03164486, a Early Phase 1 study of Breast Carcinoma and Colorectal Carcinoma, is active but no longer recruiting, sponsored by Julie L. Sutcliffe, Ph.D.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial studies the side effects of 18F-alphavbeta6-binding-peptide and how well it works in imaging patients with primary or cancer that has spread to the breast, colorectal, lung, or pancreatic. Radiotracers, such as 18F-alphavbeta6-binding-peptide, may improve the ability to locate cancer in the body.
Conditions Studied
Interventions
- DRUG 18F-αvβ6-BP
Study Locations (1)
California
- University of California Davis Comprehensive Cancer Center - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2016-11 |
| Est. Completion | 2026-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03164486
The ClinicalTrials.gov registry entry for NCT03164486 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 770-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (96% lower). The listed sponsor is Julie L. Sutcliffe, Ph.D, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 8 conditions, with Breast Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which 18F-αvβ6-BP is the first listed.
NCT03164486 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03164486 about?
NCT03164486 is a clinical study titled "First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide". This clinical trial studies the side effects of 18F-alphavbeta6-binding-peptide and how well it works in imaging patients with primary or cancer that has spread to the breast, colorectal, lung, or pancreatic. Radiotracers, such as 18F-alphavbeta6-binding-peptide, may improve the ability to locate ca...
What is the current status of trial NCT03164486?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 27 participants. The study started on 2016-11. Estimated completion is 2026-12.
What conditions does trial NCT03164486 study?
This clinical trial studies the following conditions: Breast Carcinoma, Colorectal Carcinoma, Lung Carcinoma, Pancreatic Carcinoma, Metastatic Malignant Neoplasm in the Lung.
What interventions are being tested in trial NCT03164486?
The interventions under investigation include: 18F-αvβ6-BP (DRUG).
Who is sponsoring clinical trial NCT03164486?
This trial is sponsored by Julie L. Sutcliffe, Ph.D, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03164486 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer
RECRUITING · Early Phase 1
-
MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors
RECRUITING · Early Phase 1
-
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues
ACTIVE NOT RECRUITING · Early Phase 1
-
MR Correlated Spectroscopic Imaging for Diagnosing Breast Cancer
COMPLETED · Early Phase 1
-
Surviving Daily Life
RECRUITING
-
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.